And as we age, the rate of absorption only decreases
Studies in animal models of inflammatory bowel disease (IBD) demonstrate BPC-157 can reduce inflammation, promote mucosal healing, and protect against intestinal damage
Standard / Gradual Approach (3 mL = 3.33 mg/mL total blend) Reconstitute: Add 3.0 mL bacteriostatic water to one 10 mg blend vial final concentration 3.33 mg/mL total (1.67 mg/mL of each peptide)
In addition to addressing inflammation and oxidative stress through peptide therapy, its also essential to consider other aspects of health for optimal results
It is the default pairing in recovery research the reasoning behind it is considered, not arbitrary
Still, many in the performance and injury rehab communities use BPC-157 off-label for: Chronic tendinopathies Joint degeneration Gut permeability Accelerated post-surgery rehab "Despite limited clinical trials, the number of consistent anecdotal reports and supporting animal research is what drives interest in BPC-157," notes Irrgang and colleagues, Orthopaedic Journal of Sports Medicine
